Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Escherichia coli O55:H7 - : 3,4-dihydroxyphenyllactic acid {Rosmarinic acid} |
👶
Rosmarinic Acid-Rich Perilla frutescens Extract-Derived Silver Nanoparticles: A Green Synthesis Approach for Multifunctional Biomedical Applications including Antibacterial, Antioxidant, and Anticancer Activities. Molecules (Basel, Switzerland) (Molecules ) Vol: 29 Issue 6 Pages: Pub: 2024 Mar 12 Epub: 2024 Mar 12 Authors Netala VR , Hou T , Sana SS , Li H , Zhang Z , Html Article Publication |
| Decreases Escherichia coli O55:H7 - : 3,4-dihydroxyphenyllactic acid {Rosmarinic acid} |
👶
The antibacterial mechanism of perilla rosmarinic acid. Biotechnology and applied biochemistry (Biotechnol Appl Biochem ) Vol: 69 Issue 4 Pages: 1757-1764 Pub: 2022 Aug Epub: 2021 Sep 14 Authors Zhang J , Cui X , Zhang M , Bai B , Yang Y , Fan S , Publication |
| Decreases Escherichia coli O55:H7 - : 3,4-dihydroxyphenyllactic acid {Rosmarinic acid} |
👶
Rosmarinic acid alleviates intestinal inflammatory damage and inhibits endoplasmic reticulum stress and smooth muscle contraction abnormalities in intestinal tissues by regulating gut microbiota. Microbiology spectrum (Microbiol Spectr ) Vol: Issue Pages: e0191423 Pub: 2023 Aug 18 Epub: 2023 Aug 18 Authors Li K , Wu J , Xu S , Li X , Zhang Y , Gao XJ , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
